Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Sezary Syndrome 5Carcinoma, Non-Small-Cell Lung 5Lymphoma 3Leukemia, Myeloid, Acute 3Lymphoma, Primary Cutaneous Anaplastic Large Cell 2Lung Neoplasms 2Leukemia 2Carcinoma 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Sarcoma, Kaposi 1Recurrence 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1HIV Infections 1Congenital Abnormalities 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anemia, Refractory, with Excess of Blasts 1Aggression 1Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus) 1

Interventions

Tamoxifen 10Chemotherapy, Adjuvant 7Radiotherapy 5Early Intervention, Educational 5Psychiatric Rehabilitation 4Neoadjuvant Therapy 4Letrozole 4Counseling 4Behavior Therapy 4Anastrozole 4Methods 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Immunohistochemistry 3Gene Expression Profiling 3Biopsy 3Telemedicine 2Taxes 2Soybean Proteins 2Simvastatin 2Paclitaxel 2Medroxyprogesterone 2Fatty Acids, Omega-3 2Educational Status 2Docosahexaenoic Acids 2Curcumin 2Chromatography, High Pressure Liquid 2Brachytherapy 2telapristone acetate 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Carcinoma In Situ × Bexarotene × Clear all
NCT03323658 2023-01-10

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled 12 charts
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡